InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
4
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-30.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Collins Cooper C.. Officer active across 1 company, notably TherapeuticsMD, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 4 buys · 0 sell. Total volume traded: €585k. History available since 17 August 2021. The latest transaction was filed on 18 February 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Collins Cooper C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
8,500 shares0Common StockSEC:0000905148-25-000740:0
4,094 shares@ US$1.7340.5% of flowCommon StockSEC:0000905148-24-002363:0
Canonical exit: 20 Nov 2024 (T+90)
1,200 shares@ US$1.69880.2% of flowCommon StockSEC:0000905148-24-002340:0
Canonical exit: 19 Nov 2024 (T+90)
1,984 sharesCommon StockSEC:0001209191-22-046969:0
1,000,000 shares@ US$0.578587.4% of flowCommon StockSEC:0001209191-21-066002:0
Canonical exit: 16 Feb 2022 (T+90)
100,000 shares@ US$0.7711.2% of flowCommon StockSEC:0001387131-21-008733:0
Canonical exit: 15 Nov 2021 (T+90)
96,864 sharesCommon StockSEC:0001387131-21-008436:0
7 of 7 declarations
About Collins Cooper C.
Collins Cooper C. is a declarant and is listed as a director of TherapeuticsMD, Inc. on XNAS. He has 7 filings in total, and across the recent sample of 7 filings, the transactions are acquisitions for EUR 584959 between 2021-08-12 and 2025-02-20.
